APA (7th ed.) Citation

K, A., JC, J., A, K., P, V., RJ, W., & EA, G. (2026). Baloxavir outperforms oseltamivir, favipiravir, and amantadine in treating lethal influenza A(H5N1) HA clade 2.3.4.4b infection in mice. Nature communications, 17(1), . https://doi.org/10.1038/s41467-026-69721-5

Chicago Style (17th ed.) Citation

K, Andreev, Jones JC, Kandeil A, Vogel P, Webby RJ, and Govorkova EA. "Baloxavir Outperforms Oseltamivir, Favipiravir, and Amantadine in Treating Lethal Influenza A(H5N1) HA Clade 2.3.4.4b Infection in Mice." Nature Communications 17, no. 1 (2026). https://doi.org/10.1038/s41467-026-69721-5.

MLA (9th ed.) Citation

K, Andreev, et al. "Baloxavir Outperforms Oseltamivir, Favipiravir, and Amantadine in Treating Lethal Influenza A(H5N1) HA Clade 2.3.4.4b Infection in Mice." Nature Communications, vol. 17, no. 1, 2026, https://doi.org/10.1038/s41467-026-69721-5.